Indonesia · Delayed Price · Currency is IDR IDX:LABS Statistics
Total Valuation
IDX:LABS has a market cap or net worth of IDR 572.75 billion. The enterprise value is 581.16 billion.
| Market Cap | 572.75B |
| Enterprise Value | 581.16B |
Important Dates
The next estimated earnings date is Wednesday, July 29, 2026.
| Earnings Date | Jul 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IDX:LABS has 3.95 billion shares outstanding.
| Current Share Class | 3.95B |
| Shares Outstanding | 3.95B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 3.29% |
| Owned by Institutions (%) | n/a |
| Float | 960.57M |
Valuation Ratios
The trailing PE ratio is 47.46.
| PE Ratio | 47.46 |
| Forward PE | n/a |
| PS Ratio | 2.78 |
| PB Ratio | 3.75 |
| P/TBV Ratio | 3.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 34.37 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.20, with an EV/FCF ratio of -29,517.08.
| EV / Earnings | 48.16 |
| EV / Sales | 2.82 |
| EV / EBITDA | 19.20 |
| EV / EBIT | 32.08 |
| EV / FCF | -29,517.08 |
Financial Position
The company has a current ratio of 2.75, with a Debt / Equity ratio of 0.18.
| Current Ratio | 2.75 |
| Quick Ratio | 0.98 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 0.89 |
| Debt / FCF | -1,362.78 |
| Interest Coverage | 16.60 |
Financial Efficiency
Return on equity (ROE) is 8.22% and return on invested capital (ROIC) is 9.06%.
| Return on Equity (ROE) | 8.22% |
| Return on Assets (ROA) | 5.26% |
| Return on Invested Capital (ROIC) | 9.06% |
| Return on Capital Employed (ROCE) | 11.61% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 3.81B |
| Profits Per Employee | 223.48M |
| Employee Count | 54 |
| Asset Turnover | 0.96 |
| Inventory Turnover | 1.58 |
Taxes
In the past 12 months, IDX:LABS has paid 4.02 billion in taxes.
| Income Tax | 4.02B |
| Effective Tax Rate | 24.97% |
Stock Price Statistics
The stock price has increased by +14.06% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +14.06% |
| 50-Day Moving Average | 157.42 |
| 200-Day Moving Average | 144.93 |
| Relative Strength Index (RSI) | 45.57 |
| Average Volume (20 Days) | 18,579,050 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:LABS had revenue of IDR 205.85 billion and earned 12.07 billion in profits. Earnings per share was 3.06.
| Revenue | 205.85B |
| Gross Profit | 82.47B |
| Operating Income | 18.12B |
| Pretax Income | 16.08B |
| Net Income | 12.07B |
| EBITDA | 30.03B |
| EBIT | 18.12B |
| Earnings Per Share (EPS) | 3.06 |
Balance Sheet
The company has 18.42 billion in cash and 26.83 billion in debt, with a net cash position of -8.41 billion or -2.13 per share.
| Cash & Cash Equivalents | 18.42B |
| Total Debt | 26.83B |
| Net Cash | -8.41B |
| Net Cash Per Share | -2.13 |
| Equity (Book Value) | 152.87B |
| Book Value Per Share | 38.70 |
| Working Capital | 109.47B |
Cash Flow
In the last 12 months, operating cash flow was 16.66 billion and capital expenditures -16.68 billion, giving a free cash flow of -19.69 million.
| Operating Cash Flow | 16.66B |
| Capital Expenditures | -16.68B |
| Depreciation & Amortization | 11.92B |
| Net Borrowing | -10.60B |
| Free Cash Flow | -19.69M |
| FCF Per Share | -0.00 |
Margins
Gross margin is 40.06%, with operating and profit margins of 8.80% and 5.86%.
| Gross Margin | 40.06% |
| Operating Margin | 8.80% |
| Pretax Margin | 7.81% |
| Profit Margin | 5.86% |
| EBITDA Margin | 14.59% |
| EBIT Margin | 8.80% |
| FCF Margin | n/a |
Dividends & Yields
IDX:LABS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 2.11% |
| FCF Yield | -0.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IDX:LABS has an Altman Z-Score of 6.91 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.91 |
| Piotroski F-Score | 6 |